[{"uuid": "2d1843b5-a0d5-3c60-959d-cf9c6690e37f", "title": "Aclaris Therapeutics Announces Formation of New Scientific Advisory Board", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-formation-scientific-210100795.html", "providerPublishTime": 1738270860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "1cdeae28-d96c-3adb-a9bc-c869072e49a7", "title": "Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-inducement-grants-213000876.html", "providerPublishTime": 1736199000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "936a2e11-1128-3128-a9e6-104f2be47538", "title": "HC Wainwright Upgrades Aclaris Therapeutics to Buy From Neutral, $20 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hc-wainwright-upgrades-aclaris-therapeutics-120425176.html", "providerPublishTime": 1734955465, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "2cd15bae-b1c5-35a9-abce-b72f41c62e57", "title": "Aclaris Therapeutics Files Statement for Share Resale by Stockholders; Stock Rises After Hours", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-files-statement-share-222411621.html", "providerPublishTime": 1734647051, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "9f4f13ba-0817-39d1-a53e-53d9f2b6c672", "title": "ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/acrs-stock-licensing-deal-biosion-141900379.html", "providerPublishTime": 1732025940, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS", "PFE"]}, {"uuid": "712bd1cf-c47f-3d4d-863f-782717853072", "title": "Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls", "publisher": "The Fly", "link": "https://finance.yahoo.com/news/pony-ai-thermo-fisher-initiated-143543015.html", "providerPublishTime": 1734964543, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zUit8GQVW5kcaTZHEPMI9Q--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 1200, "height": 628, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IPH9wCP.ftudEFOX7xr1MA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TMO"]}, {"uuid": "8027d954-872f-38f7-98e6-ad757aa074b5", "title": "News Flash: Analysts Just Made A Meaningful Upgrade To Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Forecasts", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/news-flash-analysts-just-made-111446349.html", "providerPublishTime": 1731410086, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "823c6c56-27ba-3106-b6fe-57a107b40f5d", "title": "Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-inc-nasdaq-acrs-141856273.html", "providerPublishTime": 1731161936, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "f5c84556-e6fd-35ce-8d73-b67724d7fa2e", "title": "Aclaris Therapeutics upgraded to Buy from Hold at Jefferies", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-upgraded-buy-hold-101103162.html", "providerPublishTime": 1732097463, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/bircVCqs.PWolEadE6JkKg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "32c97e92-04a8-3350-b020-4393f9134533", "title": "Aclaris Therapeutics upgraded to Buy from Neutral at BTIG", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-upgraded-buy-neutral-023012138.html", "providerPublishTime": 1732069812, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/EWL56DETwmfBFfnXlOrIoQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/8948b64e92d23cb05c63afbc8ed98e4c", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3wU7lIZ_DbNiCCYuX_1WbA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/8948b64e92d23cb05c63afbc8ed98e4c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "c17b4aa5-1349-3963-9afd-7b5dbfa82d01", "title": "Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/aclaris-stock-soars-analysts-see-202713999.html", "providerPublishTime": 1732048033, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_zE48bK9SSsT4KEYLSwFIQ--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/b83c0587797a48b9afbd8b99791add4f", "width": 983, "height": 553, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/lBs.o0f.1qSJf4WFXpVcUA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b83c0587797a48b9afbd8b99791add4f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "105313f8-94ac-3c8f-962c-a0032bb2e8fa", "title": "Aclaris Therapeutics Announces $80 Million Private Placement", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-80-million-131000928.html", "providerPublishTime": 1731935400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "6a60c6d3-bec4-3e6a-b850-00e810989d9a", "title": "Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-exclusive-global-131000232.html", "providerPublishTime": 1731935400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "e1c0e438-d608-3fc9-9b5c-11dc813999f3", "title": "Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-participate-piper-sandler-213000642.html", "providerPublishTime": 1732656600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "ae7b9149-efd3-3c92-9cfc-a818efc79670", "title": "Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-signs-license-agreement-144339060.html", "providerPublishTime": 1731941019, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "accc323b-7071-3da5-8411-3e1c70697727", "title": "Aclaris Therapeutics Shares Soar After Multiple Analyst Upgrades", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-shares-soar-multiple-202240348.html", "providerPublishTime": 1732047760, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "2616ca79-20ef-3346-a485-3de7bd8635a5", "title": "Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/biosion-announces-exclusive-global-license-135000512.html", "providerPublishTime": 1731937800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VI.zAJkLvR8QsLM.b8VCuQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/88961afa50383a217034358ccd97e5dd", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/lpQcx9bS6ef.zWS5Rf.MrA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/88961afa50383a217034358ccd97e5dd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "c9c46801-6ef0-3352-84b6-0863baba1b64", "title": "Aclaris Therapeutics Raises $80 Million Through Private Placement", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-raises-80-million-140338395.html", "providerPublishTime": 1731938618, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "fb92cbca-0920-3336-83af-436baeff065a", "title": "Cantor Fitzgerald Upgrades Aclaris Therapeutics to Overweight", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cantor-fitzgerald-upgrades-aclaris-therapeutics-125347396.html", "providerPublishTime": 1732193627, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "e3662534-8127-3b96-90d8-94423e7138c7", "title": "Piper Sandler Upgrades Aclaris Therapeutics to Overweight, Price Target is $13", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/piper-sandler-upgrades-aclaris-therapeutics-125554061.html", "providerPublishTime": 1732020954, "type": "STORY", "relatedTickers": ["ACRS"]}]